低分化甲状腺癌：问题介绍、标志性特征及临床影响 - Suppr

Suppr

超能文献

Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact.

作者信息

Rosai Juan

机构信息

Department of Pathology, National Cancer Institute, Milan, Italy.

出版信息

Endocr Pathol. 2004 Winter;15(4):293-6. doi: 10.1385/ep:15:4:293.

DOI:10.1385/ep:15:4:293

PMID:15681852

Abstract

摘要

相似文献

Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact.

Endocr Pathol. 2004 Winter;15(4):293-6. doi: 10.1385/ep:15:4:293.

Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience.

Endocr Pathol. 2004 Winter;15(4):307-11. doi: 10.1385/ep:15:4:307.

Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid.

Endocr Pathol. 2004 Winter;15(4):297-305. doi: 10.1385/ep:15:4:297.

Follicular neoplasms of the thyroid: view, biases, and experiences.

Adv Anat Pathol. 2004 Nov;11(6):279-87. doi: 10.1097/01.pap.0000138143.34505.02.

Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid.

Endocr Pathol. 2004 Winter;15(4):313-7. doi: 10.1385/ep:15:4:313.

Risk group-based management of differentiated thyroid carcinoma.

J R Coll Surg Edinb. 2002 Jun;47(3):589-90; author reply 590.

Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.

Endocr Pathol. 2004 Winter;15(4):319-27. doi: 10.1385/ep:15:4:319.

[Differentiated thyroid cancer--peculiar morphological and clinical forms].

Rev Med Chir Soc Med Nat Iasi. 2005 Oct-Dec;109(4):746-52.

Poorly differentiated thyroid carcinoma--it is important.

Am J Surg Pathol. 2000 Feb;24(2):310-3. doi: 10.1097/00000478-200002000-00030.

Genetic considerations in thyroid cancer.

Cancer Control. 2006 Apr;13(2):111-8. doi: 10.1177/107327480601300205.

引用本文的文献

WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.

J Med Life. 2024 Jan;17(1):15-23. doi: 10.25122/jml-2023-0270.

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na/I Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells.

Cells. 2023 Feb 1;12(3):470. doi: 10.3390/cells12030470.

Overview of the 2022 WHO Classification of Thyroid Neoplasms.

Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14.

Adiponectin and Thyroid Cancer: Insight into the Association between Adiponectin and Obesity.

Aging Dis. 2021 Apr 1;12(2):597-613. doi: 10.14336/AD.2020.0919. eCollection 2021 Apr.

Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma.

Cancer Imaging. 2021 Jan 7;21(1):8. doi: 10.1186/s40644-020-00378-z.

The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer.

Ann Surg Treat Res. 2015 Apr;88(4):187-92. doi: 10.4174/astr.2015.88.4.187. Epub 2015 Mar 26.

Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).

Langenbecks Arch Surg. 2014 Feb;399(2):165-84. doi: 10.1007/s00423-013-1140-z.

Nodal metastasis in well-differentiated follicular carcinoma of the thyroid: Its incidence and clinical significance.

Oncol Lett. 2010 Sep;1(5):873-876. doi: 10.3892/ol_00000154. Epub 2010 Sep 1.

Inflammation in thyroid oncogenesis.

Am J Cancer Res. 2012;2(3):286-97. Epub 2012 Apr 21.

Poorly differentiated thyroid carcinoma. Are we there yet?

Endocr Pathol. 2011 Dec;22(4):190-4. doi: 10.1007/s12022-011-9176-5.

本文引用的文献

Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.

Cancer. 2002 Nov 15;95(10):2076-85. doi: 10.1002/cncr.10947.

Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component.

Am J Surg Pathol. 2002 Aug;26(8):1007-15. doi: 10.1097/00000478-200208000-00005.

Poorly differentiated carcinomas of the thyroid gland: a review of the clinicopathologic features of a series of 28 cases of a heterogeneous, clinically aggressive group of thyroid tumors.

Int J Surg Pathol. 2002 Apr;10(2):123-31. doi: 10.1177/106689690201000205.

Poorly differentiated thyroid carcinoma--it is important.

Am J Surg Pathol. 2000 Feb;24(2):310-3. doi: 10.1097/00000478-200002000-00030.

Another dissertation on poorly differentiated carcinomas: is it really necessary?

Adv Anat Pathol. 1999 Sep;6(5):281-6. doi: 10.1097/00125480-199909000-00004.

Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland.

Am J Surg Pathol. 1997 Dec;21(12):1466-73. doi: 10.1097/00000478-199712000-00009.

Insular component as a risk factor of thyroid carcinoma.

Pathol Int. 1996 Dec;46(12):939-46. doi: 10.1111/j.1440-1827.1996.tb03572.x.

Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid.

Am J Surg Pathol. 1996 Jun;20(6):686-94. doi: 10.1097/00000478-199606000-00005.

Poorly differentiated ('insular') carcinoma of the thyroid.

Pathol Int. 1995 Sep;45(9):663-8. doi: 10.1111/j.1440-1827.1995.tb03519.x.

Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns.

Am J Surg Pathol. 1993 Mar;17(3):291-301. doi: 10.1097/00000478-199303000-00010.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验